152 related articles for article (PubMed ID: 36245866)
1. Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study.
Jiang Y; Sun X; Hu M; Zhang L; Zhao N; Shen Y; Yu S; Huang J; Li H; Yu W
Front Psychiatry; 2022; 13():950602. PubMed ID: 36245866
[TBL] [Abstract][Full Text] [Related]
2. Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: A targeted metabolomics study.
Liu Y; Song X; Liu X; Pu J; Gui S; Xu S; Tian L; Zhong X; Zhao L; Wang H; Liu L; Xu G; Xie P
Psychiatry Clin Neurosci; 2021 Apr; 75(4):138-144. PubMed ID: 33421228
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia.
Wang D; Cheng SL; Fei Q; Gu H; Raftery D; Cao B; Sun X; Yan J; Zhang C; Wang J
Psychiatry Res; 2019 Feb; 272():18-29. PubMed ID: 30579177
[TBL] [Abstract][Full Text] [Related]
4. Potential plasma biomarker panels identification for the diagnosis of first-episode schizophrenia and monitoring antipsychotic monotherapy with the use of metabolomics analyses.
Song M; Liu Y; Zhou J; Shi H; Su X; Shao M; Yang Y; Wang X; Zhao J; Guo D; Liu Q; Zhang L; Zhang Y; Lv L; Li W
Psychiatry Res; 2023 Mar; 321():115070. PubMed ID: 36706560
[TBL] [Abstract][Full Text] [Related]
5. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
[No Abstract] [Full Text] [Related]
6. Identification of Plasma Biomarkers in Drug-Naïve Schizophrenia Using Targeted Metabolomics.
Su Q; Bi F; Yang S; Yan H; Sun X; Wang J; Qiu Y; Li M; Li S; Li J
Psychiatry Investig; 2023 Sep; 20(9):818-825. PubMed ID: 37794663
[TBL] [Abstract][Full Text] [Related]
7. Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study.
Al-Akl NS; Khalifa O; Ponirakis G; Parray A; Ramadan M; Khan S; Chandran M; Ayadathil R; Elsotouhy A; Own A; Al Hamad H; Decock J; Alajez NM; Albagha O; Malik RA; El-Agnaf OMA; Arredouani A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396924
[TBL] [Abstract][Full Text] [Related]
8. [Lipid metabolomic analysis in exosomes of osteonecrosis of the femoral head based on ultra performance liquid chromatography-tandem mass spectrometry].
Guo M; Zhang J
Se Pu; 2022 Feb; 40(2):123-129. PubMed ID: 35080158
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study.
Du Y; Chen L; Li XS; Li XL; Xu XD; Tai SB; Yang GL; Tang Q; Liu H; Liu SH; Zhang SY; Cheng Y
Schizophr Bull; 2021 Apr; 47(3):615-623. PubMed ID: 33159208
[TBL] [Abstract][Full Text] [Related]
10. LC-MS-Based Untargeted Metabolomics Reveals Early Biomarkers in STZ-Induced Diabetic Rats With Cognitive Impairment.
Chen R; Zeng Y; Xiao W; Zhang L; Shu Y
Front Endocrinol (Lausanne); 2021; 12():665309. PubMed ID: 34276557
[TBL] [Abstract][Full Text] [Related]
11. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.
Zhou Y; Zhang X; Chen R; Han S; Liu Y; Liu X; Gao M; Yang C; Lu D; Sun B; Chen H
Clin Rheumatol; 2020 Aug; 39(8):2325-2336. PubMed ID: 32130577
[TBL] [Abstract][Full Text] [Related]
12. Metabolite profile of COVID-19 revealed by UPLC-MS/MS-based widely targeted metabolomics.
Liu J; Li ZB; Lu QQ; Yu Y; Zhang SQ; Ke PF; Zhang F; Li JC
Front Immunol; 2022; 13():894170. PubMed ID: 35924246
[TBL] [Abstract][Full Text] [Related]
13. Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS.
Sun C; Gao M; Wang F; Yun Y; Sun Q; Guo R; Yan C; Sun X; Li Y
Biomed Chromatogr; 2020 Sep; 34(9):e4875. PubMed ID: 32384189
[TBL] [Abstract][Full Text] [Related]
14. Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia.
Huang X; Ding W; Wu F; Zhou S; Deng S; Ning Y
Neuropsychiatr Dis Treat; 2020; 16():263-271. PubMed ID: 32158211
[TBL] [Abstract][Full Text] [Related]
15. Nontargeted Metabolomic Analysis of Plasma Metabolite Changes in Patients with Adolescent Idiopathic Scoliosis.
Xiao L; Yang G; Zhang H; Liu J; Guo C; Sun Y
Mediators Inflamm; 2021; 2021():5537811. PubMed ID: 34121924
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of metabolite differences in skin between Clapp's Favorite and its mutant Red Clapp's Favorite through non-targeted metabolomics].
Mu H; Ci Z; Aisajan M; Liang Y; Liu X; DU X; Yu Q; Li Q; Li Y
Se Pu; 2021 Nov; 39(11):1203-1212. PubMed ID: 34677015
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
[TBL] [Abstract][Full Text] [Related]
18. Study on potential markers for diagnosis of renal cell carcinoma by serum untargeted metabolomics based on UPLC-MS/MS.
Wang J; Yang WY; Li XH; Xu B; Yang YW; Zhang B; Dai CM; Feng JF
Front Physiol; 2022; 13():996248. PubMed ID: 36523562
[No Abstract] [Full Text] [Related]
19. Multiple biochemical indices and metabolomics of Clonorchis sinensis provide a novel interpretation of biomarkers.
Qiu YY; Chang QC; Gao JF; Bao MJ; Luo HT; Song JH; Hong SJ; Mao RF; Sun YY; Chen YY; Liu MY; Wang CR; Liu XL
Parasit Vectors; 2022 May; 15(1):172. PubMed ID: 35590378
[TBL] [Abstract][Full Text] [Related]
20. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
